{"id":"https://openalex.org/W2093310008","doi":"https://doi.org/10.1158/1538-7445.fbcr13-a46","title":"Abstract A46: Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers","display_name":"Abstract A46: Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers","publication_year":2013,"publication_date":"2013-10-01","ids":{"openalex":"https://openalex.org/W2093310008","doi":"https://doi.org/10.1158/1538-7445.fbcr13-a46","mag":"2093310008"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.fbcr13-a46","doi":"https://doi.org/10.1158/1538-7445.fbcr13-a46","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.fbcr13-a46","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014267088","display_name":"Michael Pourdehnad","orcid":"https://orcid.org/0000-0001-8701-930X","observed_orcids":["https://orcid.org/0000-0001-8701-930X"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Pourdehnad","raw_affiliation_strings":["1University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014712960","display_name":"Morgan Truitt","orcid":"https://orcid.org/0000-0001-7012-1228","observed_orcids":["https://orcid.org/0000-0001-7012-1228"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Morgan L. Truitt","raw_affiliation_strings":["1University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030941347","display_name":"Imran N. Siddiqi","orcid":"https://orcid.org/0000-0001-8083-9639","observed_orcids":["https://orcid.org/0000-0001-8083-9639"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Imran N. Siddiqi","raw_affiliation_strings":["2University of Southern California, Los Angeles, CA,","#N# 2University of Southern California, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Southern California, Los Angeles, CA,","institution_ids":["https://openalex.org/I1174212"]},{"raw_affiliation_string":"#N# 2University of Southern California, Los Angeles, CA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081915409","display_name":"Gregory S. Ducker","orcid":"https://orcid.org/0000-0002-8651-6846","observed_orcids":["https://orcid.org/0000-0002-8651-6846"]},"institutions":[{"id":"https://openalex.org/I95457486","display_name":"University of California, Berkeley","ror":"https://ror.org/01an7q238","country_code":"US","type":"education","lineage":["https://openalex.org/I95457486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory S. Ducker","raw_affiliation_strings":["3University of California, Berkeley, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University of California, Berkeley, CA","institution_ids":["https://openalex.org/I95457486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079376363","display_name":"Kevan M. Shokat","orcid":"https://orcid.org/0000-0001-8590-7741","observed_orcids":["https://orcid.org/0000-0001-8590-7741"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevan M. Shokat","raw_affiliation_strings":["1University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023731504","display_name":"Davide Ruggero","orcid":"https://orcid.org/0000-0002-9444-5865","observed_orcids":["https://orcid.org/0000-0002-9444-5865"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Davide Ruggero","raw_affiliation_strings":["1University of California, San Francisco, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, CA,","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"19_Supplement","first_page":"A46","last_page":"A46"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10521","display_name":"RNA and protein synthesis mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.9509999752044678},{"id":"https://openalex.org/keywords/mtor","display_name":"mTOR","score":0.9810000061988831},{"id":"https://openalex.org/keywords/4e-bp1-phosphorylation","display_name":"4E-BP1 phosphorylation","score":0.968999981880188},{"id":"https://openalex.org/keywords/protein-synthesis-regulation","display_name":"protein synthesis regulation","score":0.7870000004768372},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.8159999847412109},{"id":"https://openalex.org/keywords/myc-driven-lymphoma","display_name":"MYC-driven lymphoma","score":0.8930000066757202},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9399999976158142},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.593999981880188},{"id":"https://openalex.org/keywords/mln0128","display_name":"MLN0128","score":0.996999979019165},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.9359999895095825},{"id":"https://openalex.org/keywords/eif4e","display_name":"eIF4E","score":0.8259999752044678},{"id":"https://openalex.org/keywords/ribosome-biogenesis","display_name":"ribosome biogenesis","score":0.7900000214576721},{"id":"https://openalex.org/keywords/mrna-translation","display_name":"mRNA translation","score":0.6669999957084656},{"id":"https://openalex.org/keywords/tumor-cell-survival","display_name":"tumor cell survival","score":0.6579999923706055},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.39399999380111694},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.8349999785423279}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.7204164266586304},{"id":"https://openalex.org/C2779419633","wikidata":"https://www.wikidata.org/wiki/Q7322423","display_name":"Ribosome biogenesis","level":5,"score":0.6376299262046814},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.630521833896637},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.6104570627212524},{"id":"https://openalex.org/C161295673","wikidata":"https://www.wikidata.org/wiki/Q5408696","display_name":"EIF4E","level":5,"score":0.6019308567047119},{"id":"https://openalex.org/C107846503","wikidata":"https://www.wikidata.org/wiki/Q14876061","display_name":"mTORC2","level":5,"score":0.540800929069519},{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.5318629145622253},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5054073333740234},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.4918198883533478},{"id":"https://openalex.org/C149364088","wikidata":"https://www.wikidata.org/wiki/Q185917","display_name":"Translation (biology)","level":4,"score":0.4325111210346222},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.425814151763916},{"id":"https://openalex.org/C43060935","wikidata":"https://www.wikidata.org/wiki/Q18043110","display_name":"RPTOR","level":4,"score":0.4162125885486603},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.34931421279907227},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2723767161369324},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.23163339495658875},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.18250930309295654},{"id":"https://openalex.org/C88478588","wikidata":"https://www.wikidata.org/wiki/Q42244","display_name":"Ribosome","level":4,"score":0.1461034119129181},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14421004056930542},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1330660879611969},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.09643757343292236}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.fbcr13-a46","doi":"https://doi.org/10.1158/1538-7445.fbcr13-a46","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.fbcr13-a46","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2151748280","https://openalex.org/W2948785548","https://openalex.org/W2564125894","https://openalex.org/W2179539353","https://openalex.org/W2477093972","https://openalex.org/W2068661213","https://openalex.org/W2059767477","https://openalex.org/W2093431913","https://openalex.org/W2211327644","https://openalex.org/W2297288538"],"abstract_inverted_index":{"Abstract":[0],"Myc":[1,19,32,44,63,109,146,257,297,320,339,362],"is":[2,40,162,175,203,315],"one":[3],"of":[4,31,50,78,89,114,119,131,141,150,158,192,205,235,244,263,269,281,288,304,319,384],"the":[5,25,43,76,90,189,227,242,275,293,342,385],"most":[6],"highly":[7],"activated":[8],"oncogenes":[9],"in":[10,24,33,99,137,210,265,341,370,378,392],"human":[11,248],"cancer,":[12],"yet":[13],"therapeutic":[14,97,335],"approaches":[15],"to":[16,54,153,222,247,300,323,337],"directly":[17],"target":[18],"are":[20,284],"not":[21,163],"currently":[22],"available":[23],"clinic.":[26,343],"The":[27],"evolutionarily":[28],"conserved":[29],"function":[30],"regulating":[34],"ribosome":[35],"biogenesis":[36],"and":[37,59,110,184,291,327,363],"protein":[38,68,91,126,132,371],"synthesis":[39,69,92,372],"critical":[41],"for":[42,75,177,286],"oncogenic":[45,145,321],"program.":[46],"Indeed,":[47],"deregulated":[48],"control":[49,373],"mRNA":[51],"translation":[52,121],"leads":[53,299],"increased":[55,111,261,301],"cellular":[56,178],"proliferation,":[57],"survival":[58,179,220,287,326],"genomic":[60],"instability":[61],"during":[62,180],"tumorigenesis.":[64],"Therefore,":[65],"inhibiting":[66,236],"enhanced":[67],"may":[70],"represent":[71],"an":[72,311],"attractive":[73],"strategy":[74],"treatment":[77,223],"Myc-dependent":[79,181],"cancers.":[80,101,380],"To":[81],"this":[82],"end,":[83],"we":[84,135,169,187,240],"asked":[85],"if":[86],"specific":[87,276],"components":[88],"machinery":[93],"could":[94],"be":[95],"effective":[96],"targets":[98],"Myc-driven":[100,142,211,379],"We":[102,214],"uncovered":[103],"a":[104,128,138,166,193,266,333,367],"novel":[105],"functional":[106],"link":[107],"between":[108],"mammalian":[112],"Target":[113],"Rapamycin":[115],"(mTOR)":[116],"kinase-dependent":[117],"phosphorylation":[118,149,157,174,262,303],"eukaryotic":[120],"initiation":[122,183],"factor":[123],"4E":[124],"binding":[125],"(4EBP1),":[127],"master":[129],"regulator":[130],"synthesis.":[133],"Specifically,":[134],"found":[136,170,215,316],"transgenic":[139],"model":[140],"lymphoma":[143],"that":[144,171,216,255,283,310,374],"activates":[147],"mTOR-dependent":[148,172,302],"4EBP1":[151,173,208,237,264],"prior":[152],"tumor":[154,182,325],"formation":[155],"while":[156],"other":[159],"mTOR":[160,197,229,313,364],"substrates":[161],"increased.":[164],"Employing":[165],"pharmacogenetic":[167],"approach,":[168],"required":[176,285],"maintenance.":[185],"Furthermore,":[186],"demonstrated":[188],"preclinical":[190],"efficacy":[191],"newly":[194],"developed":[195],"clinical":[196],"active":[198],"site":[199],"inhibitor":[200],"MLN0128,":[201],"which":[202,232,296],"capable":[204],"fully":[206],"blocking":[207],"phosphorylation,":[209],"hematologic":[212],"malignancies.":[213],"MLN0128":[217],"significantly":[218],"prolonged":[219],"compared":[221],"with":[224,260],"vehicle":[225],"or":[226],"allosteric":[228],"inhibitor,":[230],"RAD001,":[231],"was":[233],"incapable":[234],"phosphorylation.":[238],"Additionally,":[239],"extended":[241],"implications":[243],"our":[245,307],"findings":[246,308],"diffuse":[249],"large":[250,267],"B-cell":[251],"lymphomas":[252],"by":[253,295],"demonstrating":[254],"high":[256],"expression":[258],"correlated":[259],"cohort":[268],"patients.":[270],"Ongoing":[271],"work":[272],"will":[273],"determine":[274],"translationally":[277],"regulated":[278],"mRNAs":[279],"downstream":[280,318],"4EBP1-eIF4E":[282],"Myc-overexpressing":[289],"tumors":[290],"elucidate":[292],"mechanism":[294],"overexpression":[298],"4EBP1.":[305],"Together,":[306],"reveal":[309],"important":[312],"substrate":[314],"hyperactivated":[317],"activity":[322],"promote":[324],"confers":[328,375],"synthetic":[329,376],"lethality,":[330],"thereby":[331],"revealing":[332],"unique":[334],"approach":[336],"render":[338],"druggable":[340],"Citation":[344],"Format:":[345],"Michael":[346],"Pourdehnad,":[347],"Morgan":[348],"L.":[349],"Truitt,":[350],"Imran":[351],"N.":[352],"Siddiqi,":[353],"Gregory":[354],"S.":[355],"Ducker,":[356],"Kevan":[357],"M.":[358],"Shokat,":[359],"Davide":[360],"Ruggero.":[361],"converge":[365],"on":[366,390],"common":[368],"node":[369],"lethality":[377],"[abstract].":[381],"In:":[382],"Proceedings":[383],"Third":[386],"AACR":[387],"International":[388],"Conference":[389],"Frontiers":[391],"Basic":[393],"Cancer":[394,405],"Research;":[395],"Sep":[396],"18-22,":[397],"2013;":[398],"National":[399],"Harbor,":[400],"MD.":[401],"Philadelphia":[402],"(PA):":[403],"AACR;":[404],"Res":[406],"2013;73(19":[407],"Suppl):Abstract":[408],"nr":[409],"A46.":[410]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}